site stats

Parithera

WebParithera’s goal is to save lives by providing a minimally invasive diagnostic which analyses cancer treatment resistance and allows clinicians to adjust treatment regimen. Activity or Research Description: Development of CTC liquid biopsy technologies with single cell … Web11 Apr 2024 · Cancer Therapy Evaluation Program study 9557 (ClinicalTrials.gov identifier NCT02097225) is a phase 1 study that was designed to assess the safety and efficacy of the small-molecule HSP90 inhibitor, AT13387, in combination with dabrafenib and trametinib in BRAF V600E/K –mutant solid tumors.

Parithera raises CHF 100 000 from FIT - BioAlps

WebParithera Signals Growth Rate 0.80% Weekly Growth Weekly Growth 0.80%, 93rd % -35.5%. 530% Size Multiple 219x Median Size Multiple 219x, 100th %ile 0.00x 0.95x. 413Kx Key … Web26 Nov 2024 · Parithera receives an Innogrant The EPFL Tech Launchpad is pleased to announce they have granted an award of CHF100,000 to Parithera – an EPFL-startup which improves the efficacy of cancer … other wave bluetooth https://brain4more.com

CHF 100’000 for Parithera ExTrace Dx Cancer Tracking

WebExplore Parithera's alternatives and competitors. Medicor Biosciences. Medicor Biosciences, founded in 2006 is a development-stage company focused on drug discovery for combating cancer. Web8 Dec 2024 · See Parithera funding rounds, investors, investments, exits and more. Evaluate their financials based on Parithera's post-money valuation and revenue. Parithera Stock … WebParithera . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 17. About. Parithera is actively using 17 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and SPF. other way agency

Parithera raises CHF 100 000 from FIT - BioAlps

Category:The final three Biopôle Start-up Fund winners of 2024: Volumina …

Tags:Parithera

Parithera

Parithera Advanced Cancer Treatment Monitoring awarded …

Web19 Jul 2024 · As part of the May 2024 Swissnex Bootcamp, we interviewed the startups that both traveled to San Francisco or participated from Switzerland. Hear from CEO An... Webparithera. The Vision. Our Mission. The ExTrace. The Process. Partnerships. Careers. Contact. Scroll for more. Inquire. Please rotate your device in portrait mode for the best …

Parithera

Did you know?

Web22 Mar 2024 · Parithera aims at developing Circulating Tumor Cells (CTC) monitoring and liquid biopsies to better understand diagnostics and treatments follow-up for cancer … WebParithera SA. A medical device to detect cancer treatment resistance. Parithera’s goal is to save lives by providing a non-invasive diagnostic which analyses cancer treatment …

WebParithera is funded by École Polytechnique Fédérale de Lausanne. How much funding has Parithera raised to date? Parithera has raised CHF100K. When was the last funding round … WebParithera’s goal is to save lives by providing a minimally invasive diagnostic which analyses cancer treatment resistance and allows clinicians to adjust treatment regimen. Website...

Web26 Nov 2024 · Parithera receives an Innogrant © 2024 EPFL The EPFL Tech Launchpad is pleased to announce they have granted an award of CHF100,000 to Parithera – an EPFL-startup which improves the efficacy … WebWho is Parithera. Parithera is a company that operates in the Internet industry. It employs 21-50 people and has $1M-$5M of revenue. The company is headquartered in …

WebParithera aims to revolutionize cancer diagnosis. To help them bring their technology forward Biopôle chose to support the company with the Biopôle Start-up ...

WebParithera ExTrace enables clinicians to monitor treatment response and choose the best therapy based on single cell RNA (scRNA) sequencing data. Parithera’s innovative … otherway fontWebParithera aims to revolutionize cancer diagnosis. To help them bring their technology forward Biopôle chose to support the company with the Biopôle Start-up ... other way around or roundWeb22 Mar 2024 · Parithera aims at developing Circulating Tumor Cells (CTC) monitoring and liquid biopsies to better understand diagnostics and treatments follow-up for cancer … other way holidayWebParithera is the provider of a minimally invasive, inexpensive, and highly actionable cancer diagnosis platform to guide treatment decisions of clinicians. The company was founded in 2024 and is based in Epalinges, Switzerland. Headquarters Location Startlab, Bât. Alanine Route de la Corniche 5 Epalinges, 1066, Switzerland Suggest an edit other way around synWeb12 Aug 2024 · Born two years ago as a project, Parithera was incorporated in June 2024. As the founders explain to Startupticker.ch, there is a large unmet need to precision diagnostics in oncology. By combining technologies from ETHZ and EPFL, Parithera can fill that gap. The startup will focus on 2 markets: 1) Biopharma development by supporting ... otherway london ltdWebThe Swiss Biotech Day is organised from 24 to 25 April 2024 at the Congress Center Basel. An inspiring program with thematically focused panel discussions, exhibitions, company presentations, and partnering are the cornerstones of this networking event’s lively atmosphere. The Swiss Biotech Day is a great place to discover trends in research ... otherway london limitedWebRegister and get more services Create your personal archive Get the Newsletter Set award alarms. Get involved otherway centre